Rare diseases
Investigational molecules
Locations
Study of ritlecitinib for treating severe alopecia areata in children aged 6 to under 12 years
CzechiaStudy of SAR442970 to treat moderate to severe ulcerative colitis in adults
CzechiaStudy of ultevursen treatment in patients with retinitis pigmentosa caused by mutations in USH2A gene exon 13
BelgiumLong-term safety study of ribociclib with letrozole, tamoxifen, or goserelin acetate in patients with HR-positive, HER2-negative advanced or metastatic breast cancer
GreeceStudy of Tarlatamab alone or with FOLFIRI chemotherapy for patients with advanced digestive system or unknown origin neuroendocrine carcinomas
FranceStudy of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease
FranceStudy comparing venglustat tablets with standard therapy for adult patients with Fabry disease and left ventricular hypertrophy
AustriaStudy of RO7126209 safety and effects given by intravenous infusion in patients with early stage or mild to moderate Alzheimer's disease
PolandStudy of cagrilintide and semaglutide combination versus placebo in people with type 2 diabetes and painful diabetic peripheral neuropathy
DenmarkStudy of Intravenous Sodium Thiosulfate for Treatment of Primary Raynaud's Phenomenon
The NetherlandsStudy of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor
BulgariaLong-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
